Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
about
Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapyPreclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaNext generation sequencing in synovial sarcoma reveals novel gene mutations.Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.Soft Tissue Sarcoma Cancer Stem Cells: An OverviewAntitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
P2860
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@en
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@nl
type
label
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@en
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@nl
prefLabel
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@en
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@nl
P2093
P2860
P4510
P1476
Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
@en
P2093
Aykut Uren
Emily E Carmody Soni
Hayriye V Erkizan
Jeffrey A Toretsky
Silke Schlottman
P2860
P2888
P304
P356
10.1007/S11999-013-3065-9
P407
P577
2014-03-01T00:00:00Z